Atlas Trials

Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma

Clinical trial NCT00827671 · TERMINATED

Trial details

NCT number
NCT00827671
Sponsor
P.O. Witteveen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Resectable Esophageal Cancer
Start date
2009-03-01
Primary completion
2015-12-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.